Hematemesis (Crying Blood): Causes, Pathophysiology, Red Flags, and Evidence-Based Emergency Management

Hematemesis—commonly described as “crying blood” in lay language—refers to vomiting blood or blood-stained material, typically from an upper gastrointestinal (GI) source. Although social posts may use dramatic phrasing, the clinical meaning is serious: hemoglobin loss, hemodynamic instability, and potentially life-threatening bleeding. The seed keyword here is “cry blood,” which corresponds to the medical condition of hematenesis.

Physiology and pathophysiology begin with disruption of the GI mucosa or erosion into blood vessels. Acid injury, inflammation, infection, portal hypertension, and structural lesions can expose or rupture vessels. When bleeding occurs in the esophagus, stomach, or proximal duodenum, blood may mix with gastric secretions and appear as bright red blood, coffee-ground material, or clots. The appearance is not perfectly predictive of severity: rapid bleeding may look bright red, whereas slower bleeding may undergo partial digestion and appear darker.

Major etiologic categories include peptic ulcer disease (PUD) and erosive gastritis, esophageal or gastric varices, malignancy, and mucosal tears. PUD is strongly associated with Helicobacter pylori and nonsteroidal anti-inflammatory drug (NSAID) use; these factors promote mucosal damage and impaired healing. Variceal bleeding is most often due to portal hypertension from cirrhosis and can be triggered by increased portal pressures, infection, or alcohol-related decompensation. Mallory–Weiss syndrome, a mucosal laceration at the gastroesophageal junction from forceful retching, is another recognized cause, particularly when vomiting precedes hematemesis. Less common sources include vascular malformations, swallowed blood from severe epistaxis (to distinguish hemoptysis from true hematemesis), and coagulation disorders.

Clinical significance is driven by the risk of shock and ongoing hemorrhage. Red flags include syncope, dizziness, pallor, tachycardia, hypotension, ongoing large-volume bleeding, melena with hemodynamic compromise, severe abdominal pain, and anticoagulant use. Patients may also present with fatigue, exertional dyspnea, or signs of chronic anemia. In evaluating “cry blood,” clinicians distinguish hematemesis from hemoptysis (coughing blood), epistaxis (nasal bleeding), and swallowed blood, because management pathways differ.

The diagnostic approach emphasizes stabilization first. Initial assessment follows ABC priorities and prompt vital sign monitoring. Laboratory testing typically includes complete blood count for hemoglobin/hematocrit, coagulation studies (INR, PT, aPTT), comprehensive metabolic panel, and blood type and screen or crossmatch. Risk stratification tools such as the Glasgow-Blatchford score and Rockall score may be used to estimate bleeding severity and disposition, but they should not delay resuscitation.

Resuscitation commonly includes intravenous access, fluid resuscitation, and blood transfusion guided by thresholds (often targeting a hemoglobin level around 7 g/dL in stable patients, with higher targets in specific contexts such as ischemic heart disease). Early proton pump inhibitor (PPI) therapy is standard for suspected nonvariceal upper GI bleeding, particularly while diagnostic endoscopy is arranged. If variceal bleeding is suspected—e.g., known cirrhosis, stigmata of chronic liver disease, or massive bleeding—vasoactive therapy such as octreotide or terlipressin may be initiated, along with prophylactic antibiotics due to high infection risk in variceal hemorrhage.

Definitive diagnosis and therapy are typically achieved with urgent upper endoscopy. Endoscopic interventions can include injection therapy (e.g., epinephrine), thermal coagulation, hemoclips, or band ligation for varices. For refractory bleeding, interventional radiology with angiographic embolization or surgical options may be considered.

After bleeding control, secondary prevention targets the underlying cause: eradication of H. pylori with guideline-directed antibiotics and PPI therapy for PUD; discontinuation or minimization of NSAIDs with gastroprotection when necessary; management of liver disease and portal hypertension; and malignancy evaluation when indicated. Medication reconciliation is crucial, especially regarding anticoagulants, antiplatelets, and bleeding risks.

Because “cry blood” implies an emergent medical situation, it is essential to treat it as an emergency and seek immediate care rather than rely on online descriptions. The urgency stems from the potential for rapid deterioration, need for transfusion, and time-sensitive endoscopic hemostasis.

Source: Nemezu01 via https://x.com/Nemezu01/status/2070092609503047891